Celecoxib Capsules

Contract SPE2D2-26-D-0010 is a firm-fixed-price award issued by DLA Troop Support to Radha Pharmaceuticals Inc for the supply of Celecoxib capsules in various strengths and bottle counts. The contract has a total estimated value of $15,771,598.00, covering a five-year period of performance that includes a base year and four option years. Effective June 21, 2026, the agreement specifies delivery terms as FOB Destination, with performance and delivery centered in Hauppauge, New York. The scope of supply includes Celecoxib capsules in 50 MG, 100 MG, 200 MG, and 400 MG dosages, with quantities and unit pricing detailed across multiple line items for the base and option periods. Radha Pharmaceuticals Inc is identified as a small business meeting several socioeconomic categories, including HubZone, SDVOSB, and WOSB. The contract is governed by standard Federal Acquisition Regulation clauses, including strict requirements for supply chain security, labor standards, and the prohibition of covered telecommunications equipment. Electronic invoicing is required per DFARS regulations, and the government maintains responsibility for inspection and acceptance.